Online citations, reference lists, and bibliographies.

Effect Of Storage Temperature Of Insulin On Pharmacokinetics And Pharmacodynamics Of Insulin Mixtures Injected Subcutaneously In Subjects With Type 1 (insulin-dependent) Diabetes Mellitus

G. Perriello, E. Torlone, S. Santo, C. Fanelli, P. Feo, F. Santeusanio, P. Brunetti, G. Bolli
Published 1988 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
SummaryThese studies were undertaken to assess the influence of storage temperature of insulin vials on pharmacokinetics and pharmacodynamics of a mixture of lente insulin (Monotard HM) and regular insulin (Actrapid HM) injected subcutaneously. Seven subjects with Type 1 (insulin-dependent) diabetes mellitus were studied twice after overnight normalization of plasma glucose. A mixture of lente insulin (0.22 U/kg) and regular insulin (0.11 U/kg) was prepared from insulin vials kept either refrigerated (∼4 °C) or at room temperature (∼18 °C) and injected subcutaneoulsy (abdomen). Euglycaemia was maintained for the following 16 h by glucose infusion at variable rate. With refrigerated insulin, the plasma free insulin peak was greater (53±5 versus 45±6 mU/l) and occurred earlier (2.5±0.2 versus 6±0.3 h), and the glucose infusion rate showed a greater (16.5±1.2 versus 14.5±0.9 μmol·kg−1·min−1) and earlier peak (3.2±0.2 versus 6±0.4 h) as compared to that occurring with the non-refrigerated insulin (p<0.05). However, 6 h after insulin injection, both plasma free insulin and glucose infusion rate were 30% lower with the mixture of refrigerated as compared to that of non-refrigerated insulin (p<0.05). In contrast, when NPH-insulin (Protaphane HM) was mixed with regular insulin and injected in 4 out of the 7 diabetic patients, the storage temperature of insulin vials had no effect on the pharmacokinetics and pharmacodynamics of the mixture. Thus, the storage temperature of insulin vials profoundly influences the effects of the mixture lente/regular insulin, but does not affect the pharmacokinetics and pharmacodynamics of the mixture NPH/regular insulin.
This paper references
10.2337/diacare.3.5.623
Intermediate-acting Insulin Preparations: NPH and Lente
T. Deckert (1980)
10.1152/jappl.1976.41.4.565
Effects of arterial versus venous sampling on analysis of glucose kinetics in man.
E. McGuire (1976)
10.2337/diab.26.7.605
C-peptide Response to Glucagon: A Test for the Residual β-cell Function in Diabetes Mellitus
O. Faber (1977)
The effect of insulin mixtures in type I diabetics: influence of the intermediate acting insulin on the action of short acting insulin.
I. Goicolea (1987)
10.1007/BF00276967
Absorption kinetics and action profiles of mixtures of short-and intermediate-acting insulins
R. Heine (1984)
10.2337/diacare.5.2.77
Absorption Kinetics and Biologic Effects of Subcutaneously Injected Insulin Preparations
M. Berger (1982)
Pharmacokinetics of subcutaneously injected insulin: the miscibility of short and long-acting insulin
M Berger (1985)
10.2337/diacare.10.4.473
Miscibility of Human Semisynthetic Regular and Lente Insulin and Human Biosynthetic Regular and NPH Insulin
Pierre Olsson (1987)
The clinical effects of mixing short- and intermediate-acting insulins in the treatment of non-insulin-dependent diabetes
JD Best (1987)
10.1136/bmj.289.6459.1656-a
Miscibility of human and bovine ultralente insulin with soluble insulin.
I. Mühlhauser (1984)
Pharmacokinetics of subcutaneously injected insulin : the miscibility of short and long - acting insulin prepara - 815 tions
M Berger (1985)
10.2337/diacare.9.6.579
Assessing Effect of Mixing Insulins by Glucose-Clamp Technique in Subjects With Diabetes Mellitus
S. Colagiuri (1986)
Development of glycosylated hemoglobin Alc Auto-Analyzer
K Naka (1981)
10.2337/diacare.6.1.6
Absorption and Miscibility of Regular Porcine Insulin After Subcutaneous Injection of Insulin-treated Diabetic Patients
K. Kølendorf (1983)
10.2337/diacare.10.4.466
Absorption Kinetics and Action Profiles After Sequential Subcutaneous Administration of Human Soluble and Lente Insulin Through one Needle
H. J. Bilo (1987)
10.1172/JCI111315
Mechanisms of glucagon secretion during insulin-induced hypoglycemia in man. Role of the beta cell and arterial hyperinsulinemia.
G. Bolli (1984)
10.2337/diacare.4.3.366
Factors Influencing the Absorption, Serum Insulin Concentration, and Blood Glucose Responses After Injections of Regular Insulin and Various Insulin Mixtures
J. A. Galloway (1981)
10.1136/bmj.290.6480.1515-c
Mixing short and intermediate acting insulins: effect on postprandial blood glucose concentrations.
R. Heine (1985)
The miscibility of short acting insulins with depot insulins
BC Grootendorst (1983)
10.2337/diacare.9.6.587
Effects of Mixing Short- and Intermediate-Acting Insulins on Absorption Course and Biologic Effect of Short-Acting Preparation
G. Forlani (1986)
10.1007/BF00282244
Miscibility of human lente insulin with soluble insulin
M. Tsotsalas (1985)
10.2337/diab.32.12.1177
Reduced Solubility of Short-Acting Soluble Insulins when Mixed with Longer-Acting Insulins
M. Nolte (1983)
10.1007/BF00453496
Studies on overnight insulin requirements and metabolic clearance rate of insulin in normal and diabetic man: relevance to the pathogenesis of the dawn phenomenon
P. Feo (2004)
10.2337/diab.27.1.S170
Characterization of Seven C-peptide Antisera
O. Faber (1978)
Mixtures of intermediate-acting insulin (NPH and lente) with regular insulin: a update
JA Galloway (1982)
10.2337/diab.26.1.22
Determination of Free and Total Insulin and C-Peptide in Insulin-treated Diabetics
H. Kuzuya (1977)
10.2337/diacare.7.2.188
Insulin Pharmacokinetics
C. Binder (1984)
mellitus
K Naka (1981)
10.1111/j.1651-2227.1977.tb15128.x
THE ABSORPTION OF INSULIN
J. Schlichtkrull (1977)



This paper is referenced by
10.1016/S0168-8227(98)00021-7
Effect of physicochemical variables of regular insulin formulations on their absorption from the subcutaneous tissue.
E. Polaschegg (1998)
10.1007/BF00586461
Nocturnal spikes of growth hormone secretion cause the dawn phenomenon in Type 1 (insulin-dependent) diabetes mellitus by decreasing hepatic (and extrahepatic) sensitivity to insulin in the absence of insulin waning
G. Perriello (2004)
10.4103/ijem.IJEM_97_17
Forum for Injection Technique and Therapy Expert Recommendations, India: The Indian Recommendations for Best Practice in Insulin Injection Technique, 2017
N. Tandon (2017)
10.1136/pgmj.70.827.653
Defrosting insulin: a case report.
S. Dubrey (1994)
10.1016/S0378-6080(03)80049-1
Insulin, glucagon, and hypoglycemic drugs
H. Krans (2003)
10.1007/BF00404020
The dawn phenomenon in Type 1 (insulin-dependent) diabetes mellitus: magnitude, frequency, variability, and dependency on glucose counterregulation and insulin sensitivity
G. Perriello (2004)
INSULIN FORMULATIONS FOR BETTER SUPPLY
Sampath Nikhalashree (2013)
10.1016/j.mayocp.2016.06.010
New Insulin Delivery Recommendations.
A. Frid (2016)
VARIOUS EMERGING TECHNOLOGIES IN INSULIN DELIVERY SYSTEM
P. Shivanand (2010)
10.1155/2018/9375067
Assessment of Insulin Injection Practice of Nurses Working in a Tertiary Healthcare Center of Nepal
Shital Adhikari (2018)
Discovery and Therapeutics 1 ( 3 ) 2013 , 70-84
Dominic Thyagarajan (2013)
10.1111/pedi.12182
Introduction to ISPAD Clinical Practice Consensus Guidelines 2014 Compendium.
C. Acerini (2014)
10.1111/J.1399-5448.2007.00233.X
ISPAD Clinical Practice Consensus Guidelines 2006-2007. Insulin treatment.
Hans-Jacob Bangstad (2007)
10.2337/DIACARE.26.5.1490
Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.
P. Rossetti (2003)
10.1111/j.1399-5448.2009.00578.x
Insulin treatment in children and adolescents with diabetes.
Hans-Jacob Bangstad (2009)
Type 1 Diabetes in Children, Adolescents, and Young Adults: How to Become an Expert on Your Own Diabetes
R. Hanas (2006)
10.1016/S1262-3636(10)70002-1
New injection recommendations for patients with diabetes.
A. Frid (2010)
ISPAD Clinical Practice Consensus Guidelines 2009 Compendium
K. Robertson (2009)
10.1111/pedi.12184
ISPAD Clinical Practice Consensus Guidelines 2014. Insulin treatment in children and adolescents with diabetes.
T. Danne (2014)
Advanced and Recent Emerging Trends Trends in Insulin Drug Delivery Systems Insulin Drug Delivery Systems Insulin Drug Delivery Systems Insulin Drug Delivery Systems
Mohan Avinash (2012)
Semantic Scholar Logo Some data provided by SemanticScholar